title: Comment: Assessment of Changes in Utilization of Health-Care Services After Implementation of a Prior Authorization Policy for Atypical Antipsychotic Agents.
authors.affiliation: Medical Director and CEO, American Psychiatric Association, Clinical Professor of Psychiatry and Behavioral Sciences, Department of Psychiatry, George Washington University, Washington, DC, Clinical Professor of Psychiatry and Behavioral Sciences, Department of Psychiatry and Behavioral Science, School of Medicine, University of South Carolina, Columbia, SC, hsf@psych.org.
authors.forename: James H
authors.initials: JH
authors.lastname: Scully
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D017723:Drug Utilization Review / Q000331:legislation & jurisprudence*; D005260:Female; D006078:Government Programs; D006296:Health Services / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D015397:Program Evaluation; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents